Gritstone Oncology Inc (OQ:GRTS)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for GRTS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 13/19 Sep 12/19 Jones Elaine V Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,942  
Aug 23/19 Aug 21/19 Rousseau Raphael Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Aug 23/19 Aug 21/19 Rousseau Raphael Direct Ownership Common Stock S - Open market or private sale -10,000 $10.76
Aug 23/19 Aug 21/19 Rousseau Raphael Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $0.760
Jul 29/19 Jul 26/19 Yabannavar Vijay Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Jun 20/19 Jun 19/19 Woiwode Thomas Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Svennilson Peter Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Simon Nicholas Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Li Judith Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Krognes Steve E. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for GRTS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 13/19 Sep 12/19 Jones Elaine V Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 15,942  
Aug 23/19 Aug 21/19 Rousseau Raphael Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Aug 23/19 Aug 21/19 Rousseau Raphael Direct Ownership Common Stock S - Open market or private sale -10,000 $10.76
Aug 23/19 Aug 21/19 Rousseau Raphael Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $0.760
Jul 29/19 Jul 26/19 Yabannavar Vijay Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Jun 20/19 Jun 19/19 Woiwode Thomas Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Svennilson Peter Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Simon Nicholas Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Li Judith Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Jun 20/19 Jun 19/19 Krognes Steve E. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,570  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $GRTS

Competitors

Competitors with Recent Insider Filings
ChemoCentryx (OQ:CCXI)
Apellis Pharmaceuticals (OQ:APLS)
Twist Bioscience (OQ:TWST)